GlassScriptPhysician profile
Ashley Granato
NPI 1124747647
$1,945.61
in general payments reported to CMS, 2019-2025
29 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,383 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $430.07 | 2024 | Tezspire, Fasenra |
| Genzyme Corporation | $215.14 | 2024 | |
| Glaxosmithkline, LLC. | $189.61 | 2024-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Novartis Pharmaceuticals Corporation | $189.58 | 2024 | |
| Procept Biorobotics Corporation | $150.00 | 2025 | |
| 180 Medical, INC. | $78.43 | 2025 | |
| Sumitomo Pharma America, INC. | $54.84 | 2024-2025 | Gemtesa |
| Abbvie INC. | $51.41 | 2024-2025 | |
| Urogen Pharma, INC. | $51.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.89 | 2024 | Hyqvia, Gattex, Takhzyro |
| Abc Home Medical Supply, INC. | $47.92 | 2025 | |
| Progenics Pharmaceuticals, INC. | $47.92 | 2025 | |
| Blueprint Medicines Corporation | $38.57 | 2024 | Ayvakit |
| Pfizer INC. | $35.18 | 2024 | |
| Biocryst US Sales Co., LLC | $32.78 | 2024 | Orladeyo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $31.21 | 2024 | Dupixent |
| Medtronic, INC. | $30.43 | 2025 | Interstim |
| Kaleo, INC. | $29.12 | 2024 | Auvi-Q |
| Incyte Corporation | $27.20 | 2024 | Opzelura |
| Axonics, INC. | $24.45 | 2024 | Axonics |
| Ferring Pharmaceuticals INC. | $19.11 | 2025 | Adstiladrin |
| Amgen INC. | $17.00 | 2024 | Tezspire |
| Laborie Medical Technologies Corp. | $16.23 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Hikma Pharmaceuticals USA | $15.79 | 2024 | Ryaltris |
| Azurity Pharmaceuticals, INC. | $15.49 | 2024 | Horizant |
| Octapharma USA, INC. | $14.82 | 2024 | Cutaquig |
| Bayer Healthcare Pharmaceuticals INC. | $14.68 | 2025 | |
| Teleflex LLC | $14.09 | 2025 | Barrigel |
| Phadia US INC. | $13.65 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Granato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.